AWARDDEFINITIVE CONTRACTOther than small business
Definitive contract 75A50124C00061PARTNER THERAPEUTICS, INC.
Overview
Award facts
- Net obligations
- $12.99M
- $12,990,717of $13.68M potential value
- Period of performance
- Sep 30, 2024 to Mar 31, 2028
- Ends in 16 months
- Modifications
- 3
- Latest action Aug 8, 2025
- Contract type
- Definitive contract
- PIID 75A50124C00061
Description of requirement
PARTNER THERAPEUTICS: THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO CONFIRM LEUKINE SAFETY IN SEPSIS PATIENTS, INFORM OPTIMAL LEUKINE DOSING, EXPLORE LEUKINE EFFICACY, AS WELL AS ADVANCE DEVELOPMENT OF MONOCYTE HUMAN LEUKOCYTE ANTIGEN-DR (MHLA-DR) AS
Dates and value
- Award date
- Signed on Sep 24, 2024
- Potential end of performance
- Sep 29, 2028
- Current value
- $12,990,717Base and exercised options
- Potential value (if all options are exercised)
- $13,675,055
Obligations by fiscal year of action
- FY2024: $12,990,717
Total across 1 fiscal year: $12,990,717
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Aug 8, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationLEXINGTON, MA
UEIJ33MSDBJZMC6
CAGE code7ZTL0
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate not tax exempt
Parent companyPARTNER THERAPEUTICS, INC.
Business types and certifications
For-profit organizationCorporation (not tax-exempt)
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded by
- Department of Health and Human Services
- Office Of Assistant Secretary For Preparedness And Response
- BARDA - ASPR / DAAPPO / BARDA DCMA
- Funded from
- Administration for strategic preparedness and responseProgram activities075-1000Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Lexington, Middlesex County, Massachusetts 02421-2101
- Congressional district (place of performance)
- MA-05As reported at the time of the action
Classification and competition
Classification
Competition
- Extent competed
- Competed under SAPF
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 100
Solicitation and notices
- Solicitation ID
- EZ-BAA-22-100-SOL-00003(as reported)
- Solicitation date
- Oct 18, 2022
Contract details
- Subcontracting plan
- Plan not requiredB
- Major program
- Project title: advanced development of leukine, mhla-dr and other biomarkers predictive of sepsis p
- Cost Accounting Standards clause
- Not applicable exempt from CASX
- Certified cost or pricing data
- Yes
- Service Contract Act labor standards
- No
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
- Multi-year contract
- No
- Performance-based service acquisition
- No - service where PBA is not used.N
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Sep 24, 2024Base obligation at award: $12,990,717
- Latest action
- Aug 8, 2025 — Supplemental agreement (within scope)Modification P00003
- Latest substantive action
- Aug 8, 2025 — Supplemental agreement (within scope)Modification P00003
- Actions by type
- Base award1
- Other administrative action2
- Supplemental agreement (within scope)1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- No
- Simplified procedures for commercial items
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Inherently governmental functions
- Other functionsOT
- Recovered materials and sustainability
- Environmentally preferableF
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
- Walsh-Healey Act (materials and supplies)
- No
- Construction wage rates (Davis-Bacon)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Not a manufactured end productC
Structure
- Award or IDV
- Award
- Award type
- Definitive contractD
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7505
- Contracting office code
- 75A501
- Transactions recorded under this award key
- 4
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7505
- Funding office code
- 75A501
- Treasury accounts
- 075-2024/2025-1000-000
- Object classes
- 25.1: Advisory and assistance services
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression